Clinical Trial Update: Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Lucentis (ranibizumab) in Chilean patients with diabetic macular edema has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Retinal Vein Occlusion, Age Related Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2019-02-20